119 related articles for article (PubMed ID: 28179584)
21. Angelman syndrome scientific symposium on the structure and function of UBE3A/E6AP.
Williams C
J Child Neurol; 2009 Jul; 24(7):904-8. PubMed ID: 19617463
[TBL] [Abstract][Full Text] [Related]
22. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
[TBL] [Abstract][Full Text] [Related]
23. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
24. A PSD-95 peptidomimetic mitigates neurological deficits in a mouse model of Angelman syndrome.
Lau KA; Yang X; Rioult-Pedotti MS; Tang S; Appleman M; Zhang J; Tian Y; Marino C; Yao M; Jiang Q; Tsuda AC; Huang YA; Cao C; Marshall J
Prog Neurobiol; 2023 Nov; 230():102513. PubMed ID: 37536482
[TBL] [Abstract][Full Text] [Related]
25.
Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
[TBL] [Abstract][Full Text] [Related]
26. microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.
Maity S; Bera A; Ghosh-Choudhury N; Das F; Kasinath BS; Choudhury GG
Exp Cell Res; 2018 Mar; 364(1):5-15. PubMed ID: 29397070
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
LaSalle JM; Reiter LT; Chamberlain SJ
Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
[TBL] [Abstract][Full Text] [Related]
28. Identification of Novel Components of Target-of-Rapamycin Signaling Pathway by Network-Based Multi-Omics Integrative Analysis.
Dereli Eke E; Arga KY; Dikicioglu D; Eraslan S; Erkol E; Celik A; Kirdar B; Di Camillo B
OMICS; 2019 May; 23(5):274-284. PubMed ID: 30985253
[TBL] [Abstract][Full Text] [Related]
29. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
30. Potential therapeutic approaches for Angelman syndrome.
Bi X; Sun J; Ji AX; Baudry M
Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
[TBL] [Abstract][Full Text] [Related]
31. The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization.
Khatri N; Gilbert JP; Huo Y; Sharaflari R; Nee M; Qiao H; Man HY
J Neurosci; 2018 Jan; 38(2):363-378. PubMed ID: 29175955
[No Abstract] [Full Text] [Related]
32. α1-Na/K-ATPase inhibition rescues aberrant dendritic calcium dynamics and memory deficits in the hippocampus of an Angelman syndrome mouse model.
Rayi PR; Koyavski L; Chakraborty D; Bagrov A; Kaphzan H
Prog Neurobiol; 2019 Nov; 182():101676. PubMed ID: 31401139
[TBL] [Abstract][Full Text] [Related]
33. Yin-and-Yang of mTORC1/C2 in Angelman syndrome mice.
Bi X; Sun J; Baudry M
Oncotarget; 2015 Jun; 6(16):13844-5. PubMed ID: 26116835
[No Abstract] [Full Text] [Related]
34. Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome.
Llewellyn KJ; Nalbandian A; Gomez A; Wei D; Walker N; Kimonis VE
Neurobiol Dis; 2015 Apr; 76():77-86. PubMed ID: 25684537
[TBL] [Abstract][Full Text] [Related]
35. Halcyon days of TOR: Reflections on the multiple independent discovery of the yeast and mammalian TOR proteins.
Livi GP
Gene; 2019 Apr; 692():145-155. PubMed ID: 30639424
[TBL] [Abstract][Full Text] [Related]
36. Potassium channel dysfunction in human neuronal models of Angelman syndrome.
Sun AX; Yuan Q; Fukuda M; Yu W; Yan H; Lim GGY; Nai MH; D'Agostino GA; Tran HD; Itahana Y; Wang D; Lokman H; Itahana K; Lim SWL; Tang J; Chang YY; Zhang M; Cook SA; Rackham OJL; Lim CT; Tan EK; Ng HH; Lim KL; Jiang YH; Je HS
Science; 2019 Dec; 366(6472):1486-1492. PubMed ID: 31857479
[TBL] [Abstract][Full Text] [Related]
37. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells.
Zheng B; Wang J; Tang L; Shi J; Zhu D
Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249
[TBL] [Abstract][Full Text] [Related]
38. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
[TBL] [Abstract][Full Text] [Related]
39. mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and
Tavares C; Eloy C; Melo M; Gaspar da Rocha A; Pestana A; Batista R; Bueno Ferreira L; Rios E; Sobrinho Simões M; Soares P
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757257
[TBL] [Abstract][Full Text] [Related]
40. SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome.
Runte M; Kroisel PM; Gillessen-Kaesbach G; Varon R; Horn D; Cohen MY; Wagstaff J; Horsthemke B; Buiting K
Hum Genet; 2004 May; 114(6):553-61. PubMed ID: 15014980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
